Three Drugs Purported To Be Manufactured By ‘Meg Lifesciences’ Are Spurious: DCA Telangana

Hyderabad: V.B. Kamalasan Reddy (IPS), Director General, Telangana DCA said in press release that “It has come to the attention of the Drugs Control Administration, Telangana, that certain drugs claimed on the label as manufactured by ‘Meg Lifesciences, Khasara No. 47/5, Palli Gaon, Distt. Sirmour, 173 001,’ are being circulated in the market. Upon investigation, it has been confirmed that ‘Meg Lifesciences’ is a fictitious/non-existent company. These drugs have been found to be falsified medicines, manufactured by anti-social elements, containing no active ingredient (‘Nil’ medicine). They have been found to contain chalk powder and starch, posing significant health risks to consumers.

In light of these grave findings, the Drugs Control Administration, Telangana, hereby issues a Spurious Drug Alert and Stop Use Notice for all drugs claiming to be manufactured by ‘Meg Lifesciences.’

Consumers and healthcare professionals are informed to ‘STOP USE’ immediately – to discontinue the use of any drugs claiming to be manufactured by ‘Meg Lifesciences.’

Retailers and wholesalers are directed to ‘STOP’ the sale and distribution of any drugs bearing the label of ‘Meg Lifesciences,’ and to inform the area Drugs Inspector immediately.”

The Drugs Control Administration, Telangana, is taking stringent measures to curb the menace of spurious drugs and has seized stocks claimed to be manufactured by Meg Lifesciences worth Rs. 33.35 lakhs during the recent raids carried out by DCA. Cases have been registered against several offenders involved in this spurious drugs racket.

DCA is actively working to ensure the removal of these spurious drugs from the market.

Drugs Control Administration urges the public to remain vigilant and report any information regarding the distribution or sale of drugs from this purported manufacturer ‘Meg Lifesciences’:

  • To the nearest Drugs Control Administration Office – You may report to the local Drugs Inspector or Assistant Director, Drug Control Administration. The details of the contact number and address of the office are available on the Drugs Control Administration, Telangana website https://dca.telangana.gov.in/ under the ‘Key Contacts’ section (or)
  • To the Drugs Control Administration, Telangana Toll-Free Number 1800-599-6969, which is operational from 10:30 am to 5:00 pm on all working days.” said the press release.

Related Posts

Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

Fujifilm India, a leading healthcare technology company, has expanded its ELUXEO 8000 endoscopy portfolio with the launch of its next-generation therapeutic gastroscopes at Endocon 2026. India is witnessing a growing…

Draft bill proposes powers for DIs to inspect online pharmacy office premises

Amidst years of uncertainty over the regulation of e-pharmacies in the country, the draft Drugs, Medical Devices and Cosmetics Bill, 2026, proposes to bestow the powers with the drugs inspectors…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

Draft bill proposes powers for DIs to inspect online pharmacy office premises

Draft bill proposes powers for DIs to inspect online pharmacy office premises

Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Government

Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Government

FDA cancels drug sale licences of Cipla Pharma & Life Sciences’ Pune Carry and Forwarding unit

FDA cancels drug sale licences of Cipla Pharma & Life Sciences’ Pune Carry and Forwarding unit

Delhi DCA mandates digital tracking for controlled substances on new DMS portal

Delhi DCA mandates digital tracking for controlled substances on new DMS portal

How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?

How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?